Pooled safety evaluation for a new single-shot live-attenuated chikungunya vaccine
A single dose of VLA1553 presented with an excellent local tolerability profile and overall safety in line with that expected for a live-attenuated vaccine. The safety profile was comparable in participants aged 18-64 years and ≥65 years.
Authors
- Florian Erlsbacher
- Susanne Eder-Lingelbach
- Gerald Maurer (ORCID: https://orcid.org/0000-0002-9043-7657)
- Vera Buerger (ORCID: https://orcid.org/0009-0008-9884-1006)
- Julian Larcher‐Senn (ORCID: https://orcid.org/0000-0003-3169-1900)
- Katrin Dubischar
- Juan-Carlos Jaramillo
Institutions
- Vienna Biocenter (AT)
- Valneva (Austria) (AT)
- Data Management (Italy) (IT)
Publication Details
- Journal
- Journal of Travel Medicine
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1093/jtm/taae133
- Citations
- 13
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 7.06
Funders
- Coalition for Epidemic Preparedness Innovations